Recombinant Human IL-1β
- -
- -
BackgroundIL-1R1 is an 80 kD transmembrane glycoprotein and a member of the Ig superfamily. IL-1 binds both IL-1R1 and IL-1R2. The ligands IL-1α and IL-1β only commence when binding IL-1R1 because IL-1R2 acts as a decoy receptor and competitively antagonizes the binding of IL-1α and IL-1β, thereby reducing their biological effects. Binding of the ligands to IL-1R1 is enhanced by an accessory protein, IL-1R-AcP. IL-1α can exist as either a 31 kD precursor or an 18 kD mature form. IL-1α is a proinflammatory cell-associated cytokine and IL-1β is a 17.5 kD proinflammatory secreted cytokine. Both IL-1α and IL-1β bind to the same receptor and have similar properties that include stimulation of thymocyte proliferation via IL-2 release, B-cell maturation and proliferation, mitogenic FGF-like activity and the ability to stimulate the release of prostaglandin and collagenase from synovial cells. Furthermore, IL-1β mediates a variety of immune and inflammatory responses. IL-1β is a major cause of severe inflammation in the mouse model of Crohn’s Disease, which makes IL-1β an important target for this disease. Protein DetailsPurity >97% by SDS-PAGE and analyzed by silver stain. Endotoxin Level <0.1 EU/µg as determined by the LAL method Biological Activity The biological activity of Human IL-1 Beta was determined by a cell proliferation assay using the murine helper T cell line, D10.G4.1 (Symons, J.A. et al., Lymphokines and Interferons, a Practical Approach, 1987, M.J. Clemens, A.G. Morris, and A.J.H. Gearing, eds., IRL Press, p. 272). The expected ED<sub>50</sub> for this effect is typically <12 pg/ml. Protein Accession No. Amino Acid Sequence apvr slnctlrdsq qkslvmsgpy elkalhlqgq dmeqqvvfsm sfvqgeesnd kipvalglke knlylscvlk ddkptlqles vdpknypkkk mekrfvfnki einnklefes aqfpnwyist sqaenmpvfl ggtkggqdit dftmqfvss
N-terminal Sequence Analysis Ala117 & Pro118 State of Matter Solution Predicted Molecular Mass The predicted molecular weight of Recombinant Human IL-1 Beta is Mr 17 kDa. Additionally, the actual molecular weight as observed by migration on SDS-PAGE is 17 kDa (reducing conditions). Predicted Molecular Mass 17 Formulation This recombinant protein solution was 0.2 µm filtered and supplied in modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.4 with 5% trehalose and no calcium, magnesium, or preservatives present. Storage and Stability This lyophilized protein is stable for six to twelve months when stored desiccated at -20°C to -70°C. After aseptic reconstitution, this protein may be stored at 2°C to 8°C for one month or at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. See Product Insert for exact lot specific storage instructions. Country of Origin USA Shipping Dry Ice NCBI Gene Bank References & Citations1. Gelmann, EP. et al. (2008) Cancer Res. 68(17):6896-901. PubMed 2. Arend, WP. et al. (2003) Cytokine Growth Factor Rev. 13:323 3. Nicklin, MJ. et al. (1994) Genomics 19:382 4. Dunn, E. et al. (2001) Trends Immunol. 22:533 5. Samad, TA. et al. (2001) Nature 410:425 Certificate of AnalysisIMPORTANT Use lot specific datasheet for all technical information pertaining to this recombinant protein. |
Related Products
- -
- -
Prod No. | Description |
---|---|
I-629 | |
I-659 | |
I-672 | |
I-145 | |
I-162 | |
I-169 | |
I-212 | |
I-183 | |
I-205 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.